Elixir Medical Clinical Evaluation of the Novolimus-Eluting Coronary Stent System: A Randomized Study "EXCELLA II STUDY"

NCT00792753 · clinicaltrials.gov ↗
NA
Phase
COMPLETED
Status
360
Enrollment
INDUSTRY
Sponsor class

Conditions

Interventions

Sponsor

Elixir Medical Corporation